Efficacy and action mechanism of Imrecoxib in the treatment of axial spondyloarthritis
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2016
Price : $35 *
At a glance
- Drugs Imrecoxib (Primary) ; Celecoxib
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
- 12 Nov 2016 Status changed from recruiting to completed.
- 02 Jun 2014 New trial record